Published in Blood Weekly, April 18th, 2002
For the fourth quarter, V.I. Technologies Inc. (Vitex) reported a net loss of $1.9 million, or $0.08 per share, compared with $4.7 million, or $0.23 per share, for the fourth quarter of 2000. The fourth quarter loss includes a $2.0 million credit equal to $0.09 per share for the previously announced contingent payment from Precision Pharma Services Inc. Excluding this credit, the company lost $3.9 million, or $0.17 per share, in the fourth quarter.
For the year-ended December 29, 2001, the net loss was $23.4 million, or $1.05 per share, compared...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.